Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Possible combo??
Apr 28, 2002

Dear providers:

If anyone ear a clinical trial related on Fortovase and Norvir together (ex:Kaletra)?? and how clinical results are obtained??

Response from Dr. Aberg

Fortavase is the soft gel formulation of saquinavir. Previously saquinavir had a different formulation in a hard shell and is called invirase. There have been many studies evaluating the combination of saquinavir with norvir (ritonavir). There are studies currently in progress evaulating a once daily dose of saquinavir with ritonavir. I do not know if Abbott and Roche are developing a combined pill such as Kaletra (lopinavir/ritonavir). I have not heard of that. I would recommend that you visit the Roche Pharmaceutical web page where you can get additional information regarding the clinical trials as well as contact them for further information web page



Previous
clarification of a march post
Next
IS this suitable

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement